Impact of Bacille Calmette-Guérin revaccination on serum IgE levels in a randomized controlled trial

Peleteiro, Thaís Silva; Oliveira, Evelin Santos; Conceição, Elisabete Lopes; Nascimento-Sampaio, Francisco; Alcântara-Neves, Neuza Maria; Mendes, Carlos Mauricio Cardeal; Bessa, Theolis Costa Barbosa.
Rev. Soc. Bras. Med. Trop ; 51(1): 94-98, Jan.-Feb. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1041447

Documentos relacionados

  1. Impact of Bacille Calmette-Guérin revaccination on serum IgE levels in a randomized controlled trial.
  2. Mucosal boosting.
  3. BCG-mediated viral protection goes biphasic.
  4. Is mapping the BCG vaccine-induced immune responses the key to improving the efficacy against tuberculosis?
  5. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
  6. Molecular fate-mapping of serum antibody responses to repeat immunization.
  7. Boosters appear effective, but are they always needed?
  8. Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens.
  9. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses.
  10. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.